ER stress associated TXNIP-NLRP3 inflammasome activation in hippocampus of human Alzheimer's disease.

Neurochemistry International
Saifudeen IsmaelTauheed Ishrat


Although the exact etiology of Alzheimer's disease (AD) is poorly understood, experimental and clinical evidences suggest the contribution of neuroinflammation in the pathogenesis of AD. Pathologically, AD brain is characterized by an imbalance in redox status, elevated endoplasmic reticulum (ER) stress, synaptic dysfunction, inflammation, and progressive neurodegeneration. It has been noted that continuous accumulation of amyloid-beta (Aβ) and intracellular neurofibrillary tangles (NFTs) in AD brain trigger ER stress, which contributes to neurodegeneration. Similarly, experimental evidences supports the hypothesis that thioredoxin-interacting protein (TXNIP), an endogenous regulator of redox regulator thioredoxin (TRX), is activated by ER stress and contributes to activation of NLRP3 (NOD-like receptor protein 3) inflammatory cascade in hippocampus of the AD brain. Hippocampus of postmortem human AD and aged matched non-AD controls were analyzed for the expression ER stress markers and TXNIP-NLRP3 inflammasome at cellular and molecular levels. We found higher expression of TXNIP at protein and transcript levels in close association with pathological markers of AD such as Aβ and NFTs in AD hippocampus. In addition, our results ...Continue Reading


Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J D BuxbaumP Greengard
Jun 20, 2000·Neurobiology of Aging·H AkiyamaT Wyss-Coray
Jun 24, 2005·Acta Neuropathologica·J J M HoozemansW Scheper
Sep 6, 2006·EMBO Reports·Eva SzegezdiAfshin Samali
Dec 22, 2009·Nature Immunology·Rongbin ZhouJürg Tschopp
Dec 29, 2009·Journal of Neuroinflammation·Antero SalminenJohanna Ojala
Feb 27, 2010·European Journal of Pharmacology·Asadollah ZarifkarMaryam Moosavi
Aug 31, 2011·Journal of Alzheimer's Disease : JAD·Ana LloretJose Viña
Dec 24, 2011·Molecular Neurodegeneration·Yangling Mu, Fred H Gage
Jun 6, 2012·Molecular & Cellular Proteomics : MCP·Gregor JansenDavid Y Thomas
Jul 21, 2012·Molecular Neurobiology·Ricardo J S VianaCecília M P Rodrigues
Sep 11, 2012·Neuron·Sung Ok YoonKun Huang
Dec 15, 2012·Lancet Neurology·Benoit D RousselStefan J Marciniak
Apr 10, 2014·Molecular Neurobiology·Jie-Qiong LiLan Tan
Aug 26, 2014·Methods in Molecular Biology·Ramón CacabelosJuan C Carril
Dec 5, 2014·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Saeed Sadigh-EteghadJavad Mahmoudi
Apr 24, 2015·Alzheimer's Research & Therapy·Diego Gomez-Nicola, Delphine Boche
Apr 20, 2017·International Journal of Molecular Sciences·Qing ZhaoZhaohui He
Nov 18, 2017·The FEBS Journal·Yannis Gerakis, Claudio Hetz
Feb 7, 2018·Pharmaceutical Research·Mariarosa Anna Beatrice MeloneLorena Perrone
Nov 9, 2018·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Jefferson W KinneyBruce T Lamb
Jan 9, 2019·Frontiers in Aging Neuroscience·Ashok Kumar
Mar 12, 2020·Alzheimer's & Dementia : the Journal of the Alzheimer's Association

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.


Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis